Latest Articles
Woman’s stage 4 endometrial cancer treated successfully with combination therapy - MultiCare
Woman’s stage 4 endometrial cancer treated successfully with combination therapy MultiCare
Published: Sept. 26, 2025, 9:56 a.m.
Exploring the Promise of E7386 and Lenvatinib Combination Therapy in Endometrial Carcinoma - PharmExec
Exploring the Promise of E7386 and Lenvatinib Combination Therapy in Endometrial Carcinoma PharmExec
Published: July 18, 2025, 10:08 a.m.
Impact of Combination Therapy: Evaluating the Influence of Lenvatinib and Pembrolizumab in Relapsed Endometrial Cancer - OncLive
Impact of Combination Therapy: Evaluating the Influence of Lenvatinib and Pembrolizumab in Relapsed Endometrial Cancer OncLive
Published: April 21, 2025, 1:17 p.m.
Relugolix Combination Therapy Improves Pain, Functioning, and Quality of Life in Women with... - Medical Dialogues
Relugolix Combination Therapy Improves Pain, Functioning, and Quality of Life in Women with... Medical Dialogues
Published: Nov. 11, 2024, 3:45 p.m.
Relugolix Combination Therapy Improves Pain, Functioning, and Quality of Life in Women with Endometriosis: Study - Medical Dialogues
Relugolix Combination Therapy Improves Pain, Functioning, and Quality of Life in Women with Endometriosis: Study Medical Dialogues
Published: Nov. 11, 2024, 3:45 p.m.
Relugolix combination therapy effective, safe for premenopausal women with endometriosis - Healio
Relugolix combination therapy effective, safe for premenopausal women with endometriosis Healio
Published: June 11, 2024, 7 a.m.
Link copied to clipboard!